Release Date: March 2016Company Wide License (Global Site): USD 6,500
Number of Pages: 126
Number of Tables and Figures: 46
Synopsis: Often cited as the leading cause of irreversible blindness worldwide, glaucoma is a complex eye disease in which damage to the optic nerve leads to progressive, permanent vision loss. Although this damage is usually caused by increased IOP (Intraocular Pressure) inside the eye, even patients with normal range IOP can develop glaucoma.
Glaucoma can be treated with eye drops, injections, oral pills, laser treatment or surgery. Expected to surpass $6 Billion in global spending by the end of 2016, drugs remain the preferred approach to treat most cases of glaucoma. Despite the loss of patent protection for several blockbuster drugs which has attracted generic competition, the market is ripe for future growth with a number of novel drugs in late-stage development.
The “Glaucoma Drugs Market: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the glaucoma drugs ecosystem including application areas, delivery technologies, key trends, market drivers, challenges, investment potential, leading therapies, drug development pipeline, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for glaucoma drugs from 2016 through to 2030. The forecasts are segmented for 5 drug classes, 5 regions and 25 leading countries.
The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
For a sample of the report or any further inquiries please contact firstname.lastname@example.org
Pricing: The report is available for the following price:
Single User License: USD 2,500
Company Wide License (Single Site): USD 3,500
The report has the following key findings:
The report covers the following topics:
Historical Revenue & Forecast Segmentation:
Market forecasts are provided for each of the following submarkets and their subcategories:
Key Questions Answered:
The report provides answers to the following key questions:
List of Companies Mentioned:The following companies and organizations have been reviewed, discussed or mentioned in the report:
Bausch & Lomb
D.Western Therapeutics Institute
FDA (Food and Drug Administration)
Merck & Co.
Otsuka Pharmaceutical Company
Santen Pharmaceutical Company
Teva Pharmaceutical Industries
Valeant Pharmaceuticals International